A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
Business description not available.
| Metric | TTM | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | 42.1B | 42.1B | 33.8B | 25.0B | 22.3B | 19.6B |
| Net Income | 14.6B | 14.6B | 12.2B | 7.9B | 7.6B | 6.5B |
| EPS | $3.28 | $3.28 | $2.71 | $1.73 | $1.65 | $2.77 |
| Free Cash Flow | 10.7B | 10.7B | 12.1B | 9.4B | 7.7B | 7.1B |
| ROIC | 79.7% | 43.0% | 61.3% | 54.2% | 54.3% | 67.6% |
| Gross Margin | 84.7% | 84.7% | 84.6% | 83.9% | 83.2% | 83.5% |
| Debt/Equity | 0.00 | 0.73 | 0.36 | 0.44 | 0.34 | 0.18 |
| Dividends/Share | $1.44 | $1.44 | $1.03 | $0.79 | $0.74 | $1.33 |
| Operating Income | 18.6B | 18.6B | 14.9B | 10.6B | 9.3B | 8.3B |
| Operating Margin | 44.2% | 44.2% | 44.2% | 42.3% | 41.7% | 42.6% |
| ROE | 70.4% | 70.4% | 78.5% | 66.5% | 67.5% | 66.5% |
| Shares Outstanding | 4,455M | 4,455M | 4,482M | 4,529M | 4,592M | 2,335M |
| Metric | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 17.7B | 18.3B | 19.6B | 22.3B | 25.0B | 33.8B | 42.1B | 42.1B |
| Gross Margin | 84.2% | 83.5% | 83.5% | 83.2% | 83.9% | 84.6% | 84.7% | 84.7% |
| R&D | -2.3B | -2.1B | -2.4B | -2.8B | -3.4B | -4.7B | -7.0B | -7.0B |
| SG&A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT | 7.5B | 7.9B | 8.3B | 9.3B | 10.6B | 14.9B | 18.6B | 18.6B |
| Op. Margin | 42.2% | 43.0% | 42.6% | 41.7% | 42.3% | 44.2% | 44.2% | 44.2% |
| Net Income | 6.1B | 5.8B | 6.5B | 7.6B | 7.9B | 12.2B | 14.6B | 14.6B |
| Net Margin | 34.5% | 31.9% | 33.2% | 33.9% | 31.4% | 36.0% | 34.8% | 34.8% |
| Non-Recurring | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Returns on Capital | ||||||||
| ROIC | 73.9% | 79.9% | 67.6% | 54.3% | 54.2% | 61.3% | 43.0% | 79.7% |
| ROE | 74.5% | 67.6% | 66.5% | 67.5% | 66.5% | 78.5% | 70.4% | 70.4% |
| ROA | N/A | 31.0% | 29.1% | 24.6% | 23.0% | 26.6% | 21.7% | 21.7% |
| Cash Flow | ||||||||
| Op. Cash Flow | 7.1B | 7.0B | 8.0B | 8.7B | 11.2B | 15.9B | 17.5B | 17.5B |
| Free Cash Flow | 5.5B | 5.7B | 7.1B | 7.7B | 9.4B | 12.1B | 10.7B | 10.7B |
| Owner Earnings | 6.4B | 6.2B | 7.1B | 7.8B | 10.1B | 14.5B | 14.8B | 14.8B |
| CapEx | 1.5B | 1.3B | 897M | 1.0B | 1.7B | 3.8B | 6.8B | 6.8B |
| Maint. CapEx | 621M | 849M | 886M | 956M | 1.0B | 1.4B | 2.8B | 2.8B |
| Growth CapEx | 903M | 490M | 11M | 49M | 677M | 2.4B | 4.1B | 4.1B |
| D&A | 621M | 849M | 886M | 956M | 1.0B | 1.4B | 2.8B | 2.8B |
| CapEx/OCF | 21.6% | 19.1% | 11.2% | 11.5% | 15.4% | 23.7% | 39.0% | 39.0% |
| Capital Allocation | ||||||||
| Dividends Paid | 3.0B | 2.9B | 3.1B | 3.4B | 3.6B | 4.6B | 6.4B | 6.4B |
| Dividend Yield | 5.2% | 4.8% | 4.1% | 1.7% | 1.4% | 1.2% | 1.2% | 0.6% |
| Share Buybacks | 2.5B | 2.3B | 2.6B | 3.1B | 3.4B | 4.4B | 2.9B | 2.9B |
| Buyback Yield | 4.5% | 3.3% | 3.0% | 1.2% | 1.1% | 0.9% | 0.7% | 0.3% |
| Stock-Based Comp | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Debt Repayment | 0 | 123M | 146M | 1.1B | 1.9B | 214M | 918M | 918M |
| Balance Sheet | ||||||||
| Net Debt | N/A | -956M | -139M | 2.1B | 3.4B | 3.5B | 12.9B | -2.3B |
| Cash & Equiv. | 2.5B | 2.3B | 1.9B | 1.7B | 1.8B | 2.1B | 2.3B | 2.3B |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Debt/Equity | N/A | 0.16 | 0.18 | 0.34 | 0.44 | 0.36 | 0.73 | 0.00 |
| Interest Coverage | 26.9 | 13.1 | 20.6 | 23.9 | 12.5 | 121.4 | 17.5 | 17.5 |
| Equity | 8.2B | 8.6B | 9.8B | 11.2B | 11.8B | 15.5B | 20.8B | 20.8B |
| Total Assets | 0 | 18.8B | 22.3B | 30.9B | 34.1B | 45.8B | 67.5B | 67.5B |
| Total Liabilities | 0 | 10.2B | 12.6B | 19.6B | 22.3B | 30.3B | 46.7B | 46.7B |
| Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings | 0 | 8.7B | 9.8B | 11.4B | 11.4B | 15.3B | 20.9B | 20.9B |
| Working Capital | N/A | 521M | -688M | -2.2B | -1.8B | -4.4B | -8.2B | -8.2B |
| Current Assets | 0 | 9.4B | 10.1B | 13.6B | 15.3B | 20.3B | 23.3B | 23.3B |
| Current Liabilities | 0 | 8.8B | 10.8B | 15.8B | 17.1B | 24.7B | 31.5B | 31.5B |
| Per Share Data | ||||||||
| EPS | 2.52 | 2.46 | 2.77 | 1.65 | 1.73 | 2.71 | 3.28 | 3.28 |
| Owner EPS | 2.66 | 2.60 | 3.05 | 1.69 | 2.23 | 3.23 | 3.31 | 3.31 |
| Book Value | 3.39 | 3.64 | 4.18 | 2.44 | 2.61 | 3.46 | 4.67 | 4.67 |
| Cash Flow/Share | 2.78 | 2.82 | 3.16 | 1.86 | 1.96 | 3.02 | 3.90 | 3.90 |
| Dividends/Share | 1.24 | 1.23 | 1.33 | 0.74 | 0.79 | 1.03 | 1.44 | 1.44 |
| Shares Out. | 2.4B | 2.4B | 2.3B | 4.6B | 4.5B | 4.5B | 4.5B | 4.5B |
| Valuation | ||||||||
| P/E Ratio | 9.0 | 11.9 | 13.3 | 35.4 | 38.6 | 38.1 | 27.1 | 73.4 |
| P/FCF | 9.9 | 12.3 | 12.1 | 34.6 | 32.0 | 38.3 | 37.0 | 100.3 |
| EV/EBIT | N/A | 8.7 | 10.3 | 29.0 | 28.9 | 31.3 | 22.0 | 57.6 |
| Price/Book | 6.7 | 8.1 | 8.8 | 23.8 | 25.6 | 29.9 | 19.0 | 51.6 |
| Price/Sales | 3.1 | 3.8 | 4.4 | 12.0 | 12.1 | 13.7 | 9.4 | 25.5 |
| FCF Yield | 10.1% | 8.2% | 8.3% | 2.9% | 3.1% | 2.6% | 2.7% | 1.0% |
| Market Cap | 54.9B | 69.6B | 86.1B | 267.4B | 302.4B | 463.3B | 395.3B | 1.1T |
| Avg. Price | 24.09 | 25.53 | 32.64 | 43.79 | 54.54 | 84.76 | 122.28 | 240.65 |
| Year-End Price | 22.69 | 29.33 | 36.89 | 58.23 | 66.76 | 103.36 | 88.73 | 240.65 |
Novo Nordisk B A/S passes 7 of 9 quality checks, indicating strong fundamentals.
Novo Nordisk B A/S trades at 73.4x trailing earnings, compared to its 15-year median P/E of 27.1x, suggesting it is currently Expensive relative to its historical range. On a free-cash-flow basis, the stock trades at 100.3x vs a median of 32.0x. The company's 5-year average ROIC is 56.1% with a gross margin of 84.0%. Total shareholder yield (dividends + buybacks) is 0.9%. At current prices, the estimated annualized return to fair value is +13.6%.
Novo Nordisk B A/S (NOVO-B-CO) has a current P/E ratio of 73.4, compared to its historical median P/E of 27.1. The stock is currently considered Expensive based on its historical valuation range.
Novo Nordisk B A/S (NOVO-B-CO) has a 5-year average return on invested capital (ROIC) of 56.1%. This indicates strong capital allocation and a potential competitive advantage.
Novo Nordisk B A/S (NOVO-B-CO) has a market capitalization of $1.1T. It is classified as a mega-cap stock.
Yes, Novo Nordisk B A/S (NOVO-B-CO) pays a dividend with a trailing twelve-month yield of 0.60%. The company also returns capital through share buybacks, with a buyback yield of 0.27%.
Based on historical P/E analysis, Novo Nordisk B A/S (NOVO-B-CO) appears expensive. The current P/E of 73.4 is 171% above its historical median of 27.1. The estimated fair value CAGR (P/E method) is 17.1%.
Novo Nordisk B A/S (NOVO-B-CO) reported annual revenue of $42.1 billion in its most recent fiscal year, based on SEC EDGAR filings.
Novo Nordisk B A/S (NOVO-B-CO) has a net profit margin of 34.8%. This is a strong margin indicating high profitability.
Novo Nordisk B A/S (NOVO-B-CO) generated $10.7 billion in free cash flow in its most recent fiscal year. Positive free cash flow supports dividends, buybacks, and debt reduction.
Novo Nordisk B A/S (NOVO-B-CO) has a debt-to-equity ratio of 0.73. This indicates moderate leverage.
Novo Nordisk B A/S (NOVO-B-CO) reported earnings per share (EPS) of $3.28 in its most recent fiscal year.
Novo Nordisk B A/S (NOVO-B-CO) has a return on equity (ROE) of 70.4%. This indicates the company generates strong returns for shareholders.
Novo Nordisk B A/S (NOVO-B-CO) has a 5-year average gross margin of 84.0%. This high margin suggests strong pricing power and a potential competitive moat.
The Ledger Terminal provides 7 years of financial data for Novo Nordisk B A/S (NOVO-B-CO), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
Novo Nordisk B A/S (NOVO-B-CO) has a book value per share of $4.67, based on its most recent annual SEC filing.
No recent press releases.